SMA Europe is hodling its second annual meeting of the year, kindly hosted by the German neuromuscular disease association, DGM (Deutsche Gesellschaft für Muskelkranke e.V.) in Berlin between 13th & 14th October 2017.
The programme will include:
- Individual meetings with the main pharmaceutical companies involved in the development of therapies for SMA (Avexis, Biogen, Novartis & Roche);
- A visit from the Ministry of Health;
- SMA Europe internal meeting.